Rho Chi Post

An award-winning, electronic, student-operated newsletter publication by the St. John's University College of Pharmacy and Health Sciences Rho Chi Beta Delta chapter

Menu

Skip to content
  • Home
  • Issues
    • Current Issue
    • All Issues
  • Articles
    • Featured
    • In the News / Politics
    • Events
    • Clinical
    • Advice / Opinions
    • Puzzles
    • Recently in PubMed
  • For Authors
    • Author Guidelines
    • AMA Citation Generator
    • Sign Up for Article(s)
    • Suggest Article(s)
    • Submit Article(s)
    • Check Statuses
    • Cite Your Article
  • About Us
    • About the Rho Chi Post
    • The Editorial Team
  • Apply for a Position
  • Subscribe
  • Login
Featured / In the News / Politics

The Opioid Debate: PROP and PR...

By: Tamara Yunusova – On Wednesday, July 25th a petition signed by the reform group Physicians for Responsible Opioid Prescribing (PROP) called on the FDA to implement opioid label changes that would restrict Chronic Non-Cancer (CNCP) opioid treatment for patients with severe pain only.  It wasn’t too long before another petition signed by PROP’s adversary,…

Featured / In the News / Politics

New Healthcare Law Concerning ...

By: Katie Cimmino, Pharm D. Candidate c/o 2015 –  With the start of the New Year the French government is enacting a new law concerning contraceptives. Now girls between the ages of 15 to 18 will be able to obtain free birth control.  Not only will they have access to it, but the French government…

Clinical / Featured / In the News / Politics

FDA Approves Apixaban For Nonv...

By: Alexandra Alleva, PharmD candidate c/o 2013 – As of December 28th, Bristol-Myers Squibb and Pfizer’s brand name oral anticoagulant, Eliquis® (apixaban), attained FDA approval.1  This occurred one month after its approval in  Europe and Canada, following longer than expected waits in the US due to further investigation requests by the FDA.2 The much-anticipated anticoagulant is…

Featured / In the News / Politics

White House Petition Seeks to ...

By: Mohamed Dungersi, Associate Student Editor – A recent We the People petition on the White House official website has reached the 25,000 signature threshold needed to trigger an official response.  The petition tilted “Recognize pharmacists as health care providers”, was initiated by the current editor in chief of the Rho Chi Post, Steve Soman.1 …

Featured / In the News / Politics / Professional Advice / Opinions

Tackling America’s Drug Shor...

By: John S Lim, PharmD Candidate c/o 2013 – America’s focus on healthcare, as well as its position as one of the wealthiest nations of the industrialized world, is incongruous with the consequences of drug shortages suffered by its population. Shortages in pharmaceutical supply compromise quality of life while increasing health care costs. The pharmaceutical…

Clinical / Featured

Breakthroughs in Gene Therapy:...

By: Tamara Yunusova, PharmD Candidate c/o 2017 – Gene therapy? You scoff in disbelief as thoughts of designer babies, liberal eugenics, clones, and ruthless dystopian societies begin to reel in the back of your mind. Perhaps you may even stop to recall a scene or two from Jurassic Park or Star Trek. Undoubtedly, gene therapy…

Featured / In the News / Politics

Adverse Events from Ingestion ...

By Tasnima Nabi, PharmD Candidate c/o 2016 – The FDA has issued warnings on accidental ingestion of over-the-counter eye drops and nasal sprays because they can cause serious harm in children at and under the age of five. Ingestion of as little as 0.6 ml of OTC nasal decongestants and redness-relief eye drops has been…

Featured / In the News / Politics / Professional Advice / Opinions

Giving a Second Chance: The Pr...

By: Maria Sorbera, PharmD Candidate c/o 2013 at AMSCOP (LIU) – Author William S. Burroughs states in his novel, “The question is frequently asked: Why does a man become a drug addict?  The answer is that he usually does not intend to become an addict. You don’t wake up one morning and decide to be…

Events / Featured

A Memorable Moment: The White ...

By: Tasnima Nabi, PharmD Candidate c/o 2016 – The most memorable moment of a professional’s career is when he or she is handed a symbol of what represents the culture and esteem of the chosen profession. For pharmacy students embarking upon a very intensive yet rewarding path, a white coat welcomes us into the pharmacy…

Clinical / Featured

Mechanisms of NSAID Induced Fu...

By: James W.  Schurr & Stephen Argiro, PharmD Candidates c/o 2014 – Patients frequently utilize non-steroidal anti-inflammatory drugs (NSAIDs) for a wide variety of conditions, including but not limited to arthritis, headaches, and generalized pain.  Despite an excellent safety profile, NSAIDs are associated with certain toxicities, including renal complications (particularly among at risk populations).1  Acute…

Clinical / Featured

Ivacaftor (KalydecoTM): Target...

By: Eugene Kolomiyets, PharmD Candidate c/o 2013, AMSCOP at LIU – Cystic fibrosis (CF) is an autosomal recessive disease caused by a mutation in the cystic fibrosis transmembrane conductance regulator (CFTR) gene located on chromosome 7.1  The disease has been linked to thousands of possible mutations, but only as many as 25-30 are tested for…

Clinical / Featured

Low-dose SSRIs for the Overly ...

By Sunhae Chang, PharmD Candidate c/o 2013 – When patients complain of heartburn, the blame usually shifts to gastroesophageal reflux disease (GERD).  Therefore, patients receive the “standard therapies for GERD”: antacids, histamine-2 receptor antagonists (H2RAs), proton pump inhibitors (PPIs), or prokinetics.1,2  Luckily, most patients respond well to these agents.1,2  Unfortunately, the not-as-lucky ones, despite PPI…

Clinical / Featured

Duloxetine’s Effect on Blood...

By: Neal Shah, Co-Editor-in-Chief – Duloxetine is a serotonin (5HT) and norepinephrine (NE) reuptake inhibitor (SNRI) introduced to the US market in 2004, indicated for the treatment of diabetic neuropathic pain.1 A chemical figure of duloxetine is shown [in the PDF].2 It was developed in an effort to mimic tricyclic antidepressant mitigation of neuropathic pain…

Featured / In the News / Politics / Professional Advice / Opinions

NYS Legislature to Ban Selling...

By: Mahdieh Danesh Yazdi – The views expressed in this article are solely those of the author and do not reflect the views of the Rho Chi Post, Rho Chi Beta Delta Chapter, or St. John’s University College of Pharmacy and Health Sciences.   For the past few months, I have been on rotation at…

Clinical / Featured

The Role of NMDA in Electrocon...

By: Neal Shah, Co-Editor-in-Chief – Electroconvulsive therapy (ECT) is a last-line procedure in the treatment of refractory depression, among other neuropsychological disorders.1 By inducing a seizure, neurotransmitters are released and the disease state may feature a modest mitigation in symptoms.1 Seizure medications such as benzodiazepines and barbiturates are prescribed to increase or heighten the seizure…

Clinical / Featured

Medications Causing Body Tempe...

By: Elsa Thomas, Pharm.D. c/o 2013 – Human body uses various complex mechanisms to maintain its body temperature within a narrow range despite extreme environmental temperature changes as well as physiological changes. Several factors can affect body temperature such as disease states, growth, exercise, hormonal changes, and medications. Hypothermia can occurs as a result of…

Clinical / Featured

Influenza Vaccines: Projected ...

By: Joo Hee Kwon, Pharm.D. Candidate c/o 2013 – There are 3 antigenic types of influenza: A, B, and C. Influenza C causes mild illness and therefore does not cause epidemics.  In contrast, influenza A and B are capable of causing mild to severe flu and in some cases death.  An epidemic can occur depending…

Clinical / Featured

Bisphosphonates and Atypical F...

By: Steve Soman, Pharm.D. Candidate c/o 2013 – Bisphosphonates are proven to enhance bone density and reduce fracture incidence in post-menopausal women but recent data suggests they may have adverse effects with regards to bone quality.  The drugs in this class can be differentiated as non-nitrogen containing (older generation) and nitrogen containing (newer generation) medications.…

Clinical / Featured

Antiplatelet Use Following Acu...

By: Addolorata Ciccone, Co-Copy Editor – Acute Coronary Syndromes Acute coronary syndrome (ACS) is a myocardial ischemia caused by obstruction of coronary arteries.  ACS is stratified into three types, based on electrocardiogram (EKG) changes and the presence of cardiac biomarkers (e.g. troponin, creatinine phosphokinase, and myoglobin).  To guide treatment plans, it is important to identify…

Events / Featured / In the News / Politics

College Of Pharmacy And Health...

 The College of Pharmacy and Allied Health Professions has officially changed its name to the College of Pharmacy and Health Sciences.  This is the college’s second name change since it was established in 1929. In order to truly encompass the current and future educational goals of the College of Pharmacy and Allied Health Professions, the…

Clinical / Featured / Professional Advice / Opinions

Brand Vs. Generic: What Every ...

By: Marina Yermolayeva, PharmD Candidate c/o 2013 – “I’m allergic to the generic; I need the brand name medication,” is a common claim heard by many health care providers.  Managed care organizations get numerous calls from doctors and patients requesting prior authorizations to approve brand name medications whilst there are generic alternatives available on formulary.…

Clinical / Featured

Indications for Dialysis: A Mn...

By: Neal Shah, Co-Editor-in-Chief –  Dialysis is the removal of substances from intravascular circulation by filtration.1  Typically, dialysis is ordered when kidney function declines to 10–15% of normal function.2  The National Kidney Foundation’s Kidney Disease Outcome Quality Initiative (K/DOQI) recommends that planning for dialysis begin when patients reach chronic kidney disease stage 4, which is…

Featured / Professional Advice / Opinions

The Unsung Heroes...

By: Steve Soman, Co-Editor-in-Chief – As Americans, we often admire the courage and sacrifice of the men and women serving our country in the armed forces.  As members of the pharmacy community, we admire the professionalism and achievements of our colleagues making outstanding accomplishments in their respective practice settings.  However, often I think we overlook…

Clinical / Featured / In the News / Politics

Meet the new Beta 3 Agonist: M...

By: Steve P. Soman – Mirabegron (Mybetriq®), known also by the brand name Betanis®in Japan, is a new once daily oral drug.   First in its class, it is a selective β(3)-adrenoceptor agonist that improves symptoms associated with over active bladder (OAB) such as urinary incontinence, urgency, and urinary frequency by enhancing storage function and relaxing…

Clinical / Featured

Use of Donepezil in Patients w...

By: Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 – Donepezil, brand name Aricept®, is an acetylcholinesterase inhibitor indicated as monotherapy for Alzheimer’s disease, the most common form of dementia.  Cholinergic deficiency in the cortex and basal forebrain contributes to cognitive deficits in these patients.  Donepezil reversibly, noncompetitively inhibits centrally active acetylcholinesterase, the enzyme responsible for…

Clinical / Featured

Artificial Saliva Agents in Xe...

By: Neal Shah, Co-Editor-in-Chief – Xerostomia, commonly known as dry mouth, is an anti-muscarinic side effect of numerous medications.  Antidepressants, analgesics, diuretics, and antihistamines have a high propensity to cause xerostomia.1  Xerostomia may also result from Sjogren’s syndrome, Parkinson’s disease, and various chemotherapy agents.2  Traditionally, muscarinic agonists like pilocarpine have been used to reverse xerostomia.…

Clinical / Featured

Understanding Diabetic Ketoaci...

By: Mohamed Dungersi, Associate Student Editor –  What is diabetic ketoacidosis (DKA)? Diabetic ketoacidosis (DKA) is an acute complication of uncontrolled diabetes or hyperglycemia. It is usually observed in cases of extreme hyperglycemia (usually in excess of 500 mg/dl, though it can occur over 250 mg/dl).1,2  It is usually characterized by the presence of hyperglycemia,…

Clinical / Featured

The Pathophysiology of Syndeha...

By: Neal Shah, Co Editor-In-Chief – Dyskinesias are abnormal, involuntary movement disorders.  Subsets of dyskinesias include choreas and atheosis.  Chorea is irregular and sporadic contraction of muscles whereas athetosis involves a twisting and writhing of muscles.  These two dyskinesias often occur together and are thus termed choreathetosis.1  Common conditions which feature choreatheosis are Huntington’s, and…

Featured / Professional Advice / Opinions

Five Lessons Learned from Bein...

By: Laura Gianni Augusto, B.S., Pharm.D., Associate Clinical Professor, Department of Clinical Pharmacy Practice – Laura Gianni Augusto, Pharm.D., R.Ph. is an Associate Clinical Professor in the Department of Clinical Pharmacy Practice at St. John’s University College of Pharmacy and Health Sciences. She served as Assistant Dean for Experiential Pharmacy Education from 2007 to 2011.…

Clinical / Featured

Impact of Gender and Race on t...

By: Lunbao (Jerry) Huang, Pharm.D.  Candidate c/o 2013 – Pain is a very difficult condition to manage, as clinicians have only subjective findings to work with.  Opioid medications are currently the cornerstones for the management of moderate to severe pain; however, it is often problematic to determine a patient’s real ‘need’ for opioids.  Physicians’ clinical…

Clinical / Featured / Professional Advice / Opinions

The Challenges of Pediatric Cl...

By: Shannon Tellier, Associate Student Editor – The disease burden in children outweighs the number of pediatric clinical drug trials currently being conducted.  The lack of data in pediatrics leads to drugs being used off-label and without sufficient knowledge of doses, tolerability, and efficacy.  In 1975, only 22% of products in the electronic Physicians’ Desk…

Clinical / Featured

Transplantation in HIV +/- HBV...

By: Jayoung Park, Pharm.D. Candidate c/o 2013 – Traditionally, human immunodeficiency virus (HIV)-infected patients have generally been excluded from organ transplantation.1  One of the principal concerns was that immunosuppression would accelerate HIV/acquired immune deficiency syndrome (AIDS), resulting in increased mortality and a “waste” of organs.1 A study entitled, “Opportunistic Infections and Neoplasms Following Liver and…

Clinical / Featured / In the News / Politics

Naloxone Distribution Programs...

By: Mahdieh Danesh Yazdi, Associate Student Editor, with Special Thanks to Dr. Tomasz Jodlowski for his contributions to this article – In the 1990s, major urban and rural areas across the United States grappled with a common problem: drug addiction.  At that time, the drugs of choice were illicit substances (i.e. heroin).  In order to combat…

Featured / Professional Advice / Opinions

Rho Chi Post Interview with De...

By: Mohamed Dungersi & Mahdieh Danesh Yazdi, Associate Student Editors – Each month, the editors at the Rho Chi Post have the opportunity to interview one or more of our faculty members. This month, we had the tremendous opportunity to interview the dean of St. John’s University College of Pharmacy and Allied Health Professions, Dean…

Featured / Professional Advice / Opinions

Being Aware of Pharmacy Securi...

By: Sanjay Dave, Supervising Pharmacist, Class of 1985 St. John’s University College of Pharmacy and Allied Health Professions – Mr. Sanjay Dave is a St. John’s University College of Pharmacy and Allied Health Professions Graduate, Class of 1985.  Since graduation, he has worked for Pathmark Pharmacies and is currently the supervising pharmacist at Pathmark Pharmacy…

Featured / Professional Advice / Opinions

Professor of the Year: Dr. Mai...

By: Mohamed Dungersi, Associate Student Editor – Dr. William Maidhof is an Assistant Professor and Industry Professional in the Clinical Pharmacy Practice department of the St. John’s University College of Pharmacy and Allied Health Professions. He is an alumnus of St. John’s University who graduated in 1999 with a BS in Pharmacy and again in…

Featured / In the News / Politics

Update: FTC Approves Medco and...

By: Mahdieh Danesh Yazdi, with Special Thanks to: Dr. Tomasz Jodlowski – In previous issues, we discussed an upcoming $29.1 billion merger between Express Scripts Inc. and Medco Health Solutions. The merger had been previously delayed by the Federal Trade Commission (FTC). The FTC wanted to verify that this upcoming merger would not violate any antitrust…

Clinical / Featured

Role of Calcium Channel Blocke...

By: Lunbao Huang Pharm D. Candidate c/o 2013 – The seventh report of the Joint National Committee on high blood pressure (JNC-7) states that most classes of antihypertensive drugs such as angiotensin converting enzyme inhibitors (ACEIs), angiotensin-II receptor blockers (ARBs), beta-blockers (BBs), diuretics, and aldosterone-receptor antagonists can be used for hypertensive heart failure patients except…

Clinical / Featured / In the News / Politics

Sativex®: A Realistic Option ...

By: Kathlynn Ferrer, Pharm.D. Candidate c/o 2013 – Nabiximols (Sativex®) is a buccal spray that has been approved for use in the UK, Spain, Germany, Denmark, New Zealand, and Canada. The active ingredients in this product are Tetrahydrocannabinol and Cannabidiol, two kinds of cannabinoids1. Cannabinoids are chemical compounds that stimulate cannabinoid receptors and are the…

Featured / In the News / Politics / Professional Advice / Opinions

Interview with: Mr. Phil Hecke...

By: Mahdieh Danesh Yazdi – In previous issues, we discussed prescription drug abuse and several bills currently on the floor of the NYS Legislature, sponsored by Sen. Hannon which addressed the issue. On February 7th, I sat down with Sen. Hannon’s director of communications, Mr. Phil Hecken, and his legislative aide, Mr. Timothy Broschardt to…

Clinical / Featured

HMG-CoA Reductase Inhibitors A...

By: Yufan (Frank) Liu, Pharm.D. Candidate c/o 2013 – Results of numerous epidemiological studies have indicated that having high serum cholesterol can lead to coronary heart disease (CHD). 1 More specifically having high LDL cholesterol puts patients at risk for angina and heart attack.2 To reduce this risk HMG-CoA reductase inhibitors, also known as statins,…

Featured / In the News / Politics

Counterfeit Prescription Medic...

By: Lunbao (Jerry) Huang, Pharm.D. Candidate c/o 2013 – Counterfeit prescription medications are becoming a great concern for us. They have increased worldwide costs and endangered our public safety. Activities related to counterfeit drugs cost our healthcare system an estimated $75 billion in 2010. Many patients were seriously injured and died due to counterfeit medications.…

Featured / Professional Advice / Opinions

Faculty Spotlight: Dr. Hira Sh...

By: Jessica Lee, Pharm.D. Candidate c/o 2013 – Dr. Hira Shafeeq received her PharmD in 2009 from St. John’s University.  After graduating, she went on to do her PGY-1 at the Brooklyn Hospital Center.  Upon finishing her first year of residency, she decided to complete her specialty residency in critical care at University of Chicago…

Featured / Professional Advice / Opinions

Faculty Spotlight: Dr. Tran...

By: Shannon Tellier – Dr. Tran is an assistant clinical professor at St. John’s University College of Pharmacy and Allied Health Professions, and a clinical pharmacy manager in Internal Medicine at NewYork-Presbyterian: Columbia University Medical Center.  She received her BS in Public Health and Doctor of Pharmacy from the University of North Carolina at Chapel…

Featured / In the News / Politics

Inhaled Caffeine Under Investi...

By: Mahdieh Danesh Yazdi – A few months ago, a new product called AeroShot Pure Energy hit the markets in New York and Massachusetts.  AeroShot is a new inhaler that gives the user bursts of caffeine.  Each inhaler contains an estimated 100mg of caffeine, approximately the same amount as a large cup of coffee.  It…

Featured / Professional Advice / Opinions

The Changing Role of Community...

By: Charles George, Pharm.D. – Charles George, Pharm.D. is a recent graduate from the University of Florida in 2011.  He currently works as a community pharmacist for Walgreens Pharmacy in the Central Florida area.  Since graduation, his daily interaction with patients revealed the need for pharmacists to adapt to the evolving role of community pharmacy. …

Clinical / Featured

CHF, a Rare but Serious Presen...

By: James Schurr, Pharm.D. Candidate c/o 2014 – Graves’ disease is an autoimmune disorder that results in a state of thyrotoxicosis, or a cause of hyperthyroidism, due to the Immunoglobulin G-mediated agonism of thyroid stimulating hormone (TSH) receptors located on the thyroid.  Stimulation of TSH receptors causes an increase in circulating thyroxine (T4) and triiodothyronine…

Clinical / Featured

Brilinta® vs. Plavix® in Pat...

By: Ronik Saha, Pharm.D. Candidate c/o 2013 – Clopidogrel (Plavix®) is a thienopyridine antiplatelet agent, which exerts its antiplatelet effects via in vivo conversion to an active thiol metabolite that irreversibly blocks the P2Y-12 component of platelet ADP receptors.  This prevents activation of the GP2B/3A complex, thereby preventing platelet aggregation.  Along with aspirin, clopidogrel reduces…

Clinical / Featured

Proton Pump Inhibitors and the...

By: Neal Shah – Osteoporosis is a disease of the bone characterized by decreased bone mineral density (BMD), which reduces the ability of bone to provide adequate structural support.  The main cause of this decreased BMD is inadequate calcium intake or absorption.  The decreased BMD can cause diffuse lesions throughout the skeletal system and can…

Featured / Professional Advice / Opinions

Pharmacists Are Healthcare Pro...

By: Sandra Leal Pharm.D., CDE –  Sandra Leal, PharmD, CDE is the Director of Clinical Pharmacy at El Rio Health Center in Tucson, Arizona. Dr. Leal is the first pharmacist in Arizona to receive prescriptive authority under collaborative practice. She is currently the Co-Chair of HRSA’s Patient Safety and Clinical Pharmacy Services Collaborative, a national…

Post navigation

← Older posts
Newer posts →


Do You Want to be a Published Author? Submit your Article(s) Today!



Tweets by @RhoChiPost

HOME: Home Page

VOLUMES / ISSUES: 14 . 13 . 12 . 11 . 10 . 9 . 8 . 7 . 6 . 5 . 4 . 3 . 2 . 1

ARTICLES: Featured . In the News / Politics . Events . Clinical . Advice / Opinions . Puzzles

FOR AUTHORS: Guidelines . AMA Citation Generator . Sign Up . Suggest . Submit . Cite

ABOUT US: About the Rho Chi Post . The Editorial Team . Apply for a Position

SUBSCRIBE: Google Groups Email List


Copyright © 2011-2025 Rho Chi Post